Steroid hormone receptors, including estrogen receptors (ER␣ and ER␤), progesterone receptors (PR-A and PR-B)
, androgen receptors (AR), glucocorticoid receptors (GR), and mineralocorticoid receptors (MR), are ligand-inducible transcription factors that specifically regulate expression of target genes involved in metabolism, development, and reproduction. Steroid hormone receptors share a common structural organization containing three functional domains: a variable N-terminal transactivation domain, a highly conserved DNA binding domain, and a moderately well-conserved C-terminal ligand binding domain (5, 57) . There are apparent differences in conformation and coregulator binding between the N-terminal region (N) containing a ligand-independent transactivation domain, AF-1, and C-terminal region (C) containing a liganddependent transactivation domain, AF-2 (62, 65) . It has been reported that an agonist-induced intramolecular interaction, called an N-C interaction, is required for dimerization and full activities of the steroid hormone receptors (18, 31, 54) . AR belongs to the steroid hormone receptor superfamily but exhibits some specific characteristics that are different from other members. AR has a particularly long N terminus whose strong autonomous AF-1 transactivation function is dominant compared to its AF-2 function of the C terminus (27, 36) . The N terminus of AR is also an important target for coregulator proteins (2, 10) .
The activities of nuclear receptors, in general, are modulated by coregulators that are divided into coactivators and corepressors. Two corepressors, nuclear receptor corepressor (N-CoR) and silencing mediator for retinoid and thyroid hormone receptors (SMRT), were initially identified as a component of repression complexes associated with unliganded RAR and TR (8, 21) . Both N-CoR and SMRT were also found to interact with antagonist-bound PR and ER to repress their transcriptional activations (1) . One model has been proposed that, although corepressors interact with unliganded nuclear receptors and repress their transactivation of target genes, ligand-dependent release of the corepressors leads to recruitment of coactivators and transcriptional activation mediated by ligand-bound receptors (38) . The N-CoR and SMRT are thought to recruit histone deacetylase complex (HDAC) in the nuclear receptor complex to reduce the level of histone acetylation and repress transcription (28, 37, 66) . Another mechanism has also been advocated in which N-CoR/SMRT may compete with coactivators in interactions with steroid hormone receptors in the presence of antagonists (14, 26, 44) . A highly dynamic and functional architecture that governs gene expression, replication, and repair in the nucleus, including chromatins, proteins, and subnuclear bodies, has emerged in recent years. Some key components are functionally compartmentalized into specialized and punctate subnuclear domains, as documented by biochemical and in situ evidence (47) . For example, one of the pre-mRNA splicing factors, SC35, appears as 20 to 40 speckles per nucleus (67) . The promyelocytic leukemia gene product controlling aspects of apoptosis, cell proliferation, and transcriptional regulation was found within distinct subnuclear bodies, termed promyelocytic leukemia (PML) nuclear bodies (PML-NBs) (3) . Some corepressor complexes were localized in distinct subnuclear bodies line, MCF-7, were obtained from American Type Culture Collection (Manassas, VA). LNCaP, 3T3-L1, and NIH 3T3 cells were maintained in Dulbecco's modified Eagle's medium (DMEM; Invitrogen Corp., Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS) (Cansera International, Inc., Canada) and 100 U/ml penicillin-streptomycin (Invitrogen). MCF-7 cells were cultured in Eagle's minimal essential medium supplemented with 1% nonessential amino acids, 1% sodium pyruvate, 10 g/ml insulin, 10% FBS, and 100 U/ml of penicillin-streptomycin.
Functional reporter assays. Luciferase reporter assays were performed as previously described (30) . Briefly, cells (1 ϫ 10 5 cells/well) were split into 12-well plates and cultured at 37°C for 24 h before transfection. The cells were cotransfected with 0.5 g/well of pGL3-PSA, pGL3-MMTV, or pA3-ERE2 as a reporter, 2 ng/well of pRL-CMV (Promega) as an internal control, and 0.1 to 2.5 g/well expression plasmids for proteins of interest using 2.7 l/well of SuperFect transfection reagent (QIAGEN, Hilden, Germany). For coexpression studies, the total amount of vectors added to each well was equalized by the addition of empty vector. At 3 h posttransfection, DMEM containing 10% charcoaltreated FBS was added with or without 10 nM DHT, 100 nM dexamethasone (Dex), 1 M estradiol (E 2 ), or 10 ng/ml trichostatin A (TSA). After incubation for 20 to 24 h, the cells were lysed in lysis buffer from a luciferase assay kit (Promega) and then subjected to the assay for luciferase activities using the Dual-Luciferase Reporter assay system (Promega) and a Lumat LB 9507 (Berthold Technologies, Bad Wildbad, Germany).
Mammalian two-hybrid assays. COS-7 and NIH 3T3 cells were seeded into 12-well plates (1 ϫ 10 5 cells/well). For the mammalian two-hybrid assay, the cells were cotransfected with pG5 (0.1 g/well), pBIND-Gal4-AR-AF-2 (0.16 g/ well), and pACT-VP16-AR-AF-1 (0.14 g/well) together with pFLAG-CMV2-N-CoR (0.25, 0.74, or 1.2 g/well), pFLAG-CMV2-N-CoR(1-1798) (0.2 or 1.0 g/well), pYFP-N-CoR(1134-1798) (0.14 or 0.7 g/well), pcDNA-SRC-1 (0.2 or 0.6 g/well), or pcDNA/mCBP (0.26 or 0.77 g/well). The total amount of plasmids added to each well was equalized by the addition of empty vectors. After 20 to 24 h of incubation, the cells were lysed and subjected to the assay for luciferase activities.
CoIP. Coimmunoprecipitation (CoIP) was performed as previously described (25, 30) . COS-7 cells were seeded in 100-mm plates (1 ϫ 10 6 cells/plate). After incubation for 24 h, the cells were cotransfected with 1 g of pCMV-AR and 5 g of expression plasmids for green fluorescent protein (GFP)-N-CoR, GFP-N-CoR(1-1798), or GFP-N-CoR(1803-2439). In one experiment, the cells were cotransfected with 1 g of pCMV-AR and 5 g of expression plasmids for VP16, VP16-N-CoR(1-740), VP16-N-CoR(742-1798), or VP16-N-CoR(1803-2439). And in another experiment, the cells were cotransfected with 1 g of pCMV-AR and 5 g of expression plasmids for YFP, YFP-N-CoR(1-1133), or YFP-NCoR(1134-1798). Three hours after transfection, the cells were incubated with fresh DMEM in the presence of 10 nM DHT for 20 to 24 h. This was followed by two washes with ice-cold phosphate-buffered saline. The cells were then incubated on ice for 30 min in NEB buffer consisting of 20 mM HEPES-NaOH (pH 7.9), 20% glycerol, 100 mM KCl, 0.2 mM EDTA, and 0.5% NP-40 with a tablet of protease inhibitor cocktail (Sigma). The cells were scraped and then sonicated on ice by Handy Sonic (model UR-20P; Tomyseiko Co. Ltd., Tokyo, Japan) four times for 5 s and then centrifuged at 13,000 rpm for 10 min at 4°C. Supernatants were collected, and the protein concentrations were measured using a BCA protein assay kit (Pierce, Rockford, IL). Each cell lysate was adjusted to 2 mg/ml using NEB buffer. An anti-AR (C19; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) or an anti-VP16 (Santa Cruz) antibody was preincubated with 25 l of protein A magnetic beads (Amersham Bioscience Corp., Piscataway, NJ) at 4°C for 2 h with agitation. The antibody-bead mixture was added to 200 l of the cell lysate with 0.05% skim milk. The lysate mixture was incubated at 4°C for 6 h with agitation, and then the beads were washed five times with 500 l NETN buffer consisting of 20 mM Tris-HCl (pH 7.9), 100 mM NaCl, 1 mM EDTA, 0.5% NP-40, and a tablet of protease inhibitor cocktail. Proteins bound to the antibody were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis using a 6% (for the N-CoR and its mutants) or 10% (for the AR) separating gel and then transferred onto a nitrocellulose membrane (Hybond ECL; Amersham) using a Trans-Blot SD semi-dry transfer cell (Bio-Rad Laboratories, Hercules, CA). The membrane was incubated with the first antibody, anti-GFP (1:200 dilution) or anti-AR (C19, 1:200 dilution) (Santa Cruz), at 4°C overnight. After being washed three times with Tris-buffered saline (TBS)-Tween 20 (10 mM Tris-HCl [pH 8.0], 0.9% NaCl, and 0.05% Tween 20), the membrane was incubated with an appropriate amount of horseradish peroxidase-conjugated anti-rabbit antibody (Amersham) at 25°C for 1 h. After being washed three times with TBS-Tween 20, the membrane was reacted with ECL-plus Western blotting detection reagents (Amersham). The labeled protein bands were visualized and analyzed using a STORM 860 image analyzer (Amersham).
Fluorescence microscopy and image analysis. Confocal laser scanning microscopy was performed essentially as previously described (12, 30) . The COS-7 and LNCaP cells were seeded into 35-mm glass-bottom dishes (2 ϫ 10 5 cells/dish; Asahi Techno Glass Corp., Chiba, Japan) and transfected with 0.5 to 11 g/dish of various plasmids using 5 to 20 l of the SuperFect reagent. After incubation for 24 h, the cells were observed using an LSM 510 META microscope (Carl Zeiss Co. Ltd., Jena, Germany) equipped with a Plan Apochromat 63ϫ, 1.4 numerical aperture oil differential interference contrast immersion objective. For excitation of GFP and YFP, 488-nm and 514-nm argon laser lines were used, respectively. For simultaneous imaging of GFP and YFP, the 488-nm laser line was used for excitation. The detection spectrum range was set from 491 to 576 nm. Images were collected at a 12-bit depth resolution of intensities over 1024 by 1024 pixels. To separate GFP and YFP signals, raw images obtained in a mode were subjected to a META unmixing procedure (the emission fingerprinting technique established by Carl Zeiss). During simultaneous multi-imaging, cells showing a similar intensity of each fluorescence protein were selected for further study. Parameters such as laser power, laser line, dichroic beam splitter to separate excitation and emission, and scanning speed were all kept fixed during the same group of experiments. The quantitative analysis of nuclear foci in two-dimensional images was also performed using the Zeiss LSM software (version 3.0) as described previously (12, 43) . Cells showing appropriate expression levels of proteins of interest were selected under the microscope, and then fluorescent intensity numerals of each line were scanned and exported to MS Excel for calculation of averages and standard deviations (SD) as well as CV (coefficient of variation) values of the intranuclear fluorescent intensities on each line of interest. The LSM software also constructed fluorescent intensity fluctuation graphs for the line scan of the representative cells. A three-dimensional imaging study was performed essentially in the same manner as previously CoR IMPAIRS AR-MEDIATED TRANSACTIVATION  6635 reported (41, 56) with minor modifications. In brief, a series of 30 to 50 scanning two-dimensional (2D) images were collected for each single nucleus, in which signals for GFP and YFP were simultaneously obtained and subjected to a META unmixing procedure. These tomograms were reconstructed using the three-dimensional analysis software of the TRI graphics program (Ratoc System Engineering, Tokyo, Japan). First, low-intensity background noises were removed from each raw 2D image. Namely, particles became clear as the intensity was decreased from the maximal level and the number of the separated particles became constant at some intensity level, which was set as the cutoff level. This minimum intensity cutoff value was usually 25 to 30% of the dynamic range. Following the treatment with a median filter to remove small background pixels from each 2D image, three-dimensional images were then constructed and the number of foci was calculated. We always put control 2D images of ligand-bound AR foci and confirmed that the constant number was obtained. Both the distri-FIG. 2. Subcellular redistribution of exogenously expressed YFP-N-CoR by agonist-bound steroid hormone receptors. COS-7 cells were transfected with the expression plasmid for AR-GFP (A), GR␣-GFP (D), or ER␣-GFP (G) alone. Twenty-four hours after the transfection, images were collected using a laser scanning microscope before (a) and after (b) treatment with each ligand (10 nM DHT, 100 nM Dex, or 1 M E 2 ) at 37°C for 1 h. COS-7 cells were also cotransfected with the expression plasmid for AR-GFP (B and C), GR␣-GFP (E and F), or ER␣-GFP (H and I) together with the plasmid for YFP-N-CoR. Images were then collected in the absence (B, E, and H) or presence (C, F, and I) of each cognate ligand. Signals from GFP-fused steroid hormone receptors (green, i) and YFP-N-CoR (red, ii) were obtained under the microscope, and the two signals were merged (iii). The molar ratio of transfected amounts of expression plasmids for N-CoRs and steroid hormone receptors was 3:1 in each case. Bars, 5 m.
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bution and calculations of the fluorescent proteins as a distinct volume were thus made possible by removing scattering background fluorescence and lens spherical aberrations and then separating each particle. FRAP analysis. Fluorescence recovery after photobleaching (FRAP) analysis was carried out using the LSM 510 META confocal microscope as described previously (12, 50) . A region of interest (ROI) representing 20 to 25% of an area of the nucleus was photobleached by a 488-nm laser line for GFP at the maximum power of 50 iterations. After the bleaching, images within the bleached area were taken every 1 s at a resolution of 512 by 512 pixels to monitor the recovery of the fluorescence intensity. The fluorescence recovery was usually incomplete, probably because attenuation of fluorescence occurred during photobleaching and serial scanning. Therefore, we normalized the raw FRAP data (both the intensity and the time) as described by Stenoien et al. (50) . The normalized intensities were averaged and plotted against time to make the recovery curve. The logarithmic equation of the recovery curve is y ϭ a · ln(x) ϩ b, where a is the slope, b is the y-axis intercept, ln(x) is the natural logarithm function of the time, and y is the fully normalized intensity at a given time. The half-recovery time (t 1/2 ) was calculated using the following equation: x (when y ϭ 0.5) ϭ e VOL. 26, 2006 N-CoR IMPAIRS AR-MEDIATED TRANSACTIVATION 6637
Each t 1/2 was an average of results for at least 20 cells from three independent experiments. Immunofluorescence staining. Immunofluorescence staining was performed as previously described (33, 41) . Cells were seeded into 8-well Lab-Tek II chamber slide system (2 ϫ 10 4 cells/well; Nalge Nunc International, Rochester, NY) or 35-mm glass-bottom dishes (2 ϫ 10 5 cells/dish; Asahi Techno Glass Corp.) and were then transfected with the expression plasmids for proteins of interest. After being washed twice with ice-cold phosphate-buffered saline, the cells were fixed in methanol-acetone (1:1) for 10 min at Ϫ20°C. After being incubated in 1ϫ Block-Ace (Dainippon Pharmaceutical Co., Osaka, Japan) for 10 min at 25°C, the cells were incubated with rabbit anti-FLAG antibody ( Statistics. One-way analysis of variance followed by Scheffé's test was used for multigroup comparisons. A P value of Ͻ0.05 was considered statistically significant.
RESULTS

Subcellular distributions of N-CoR and truncated mutants.
Schematic diagrams of the N-CoR protein and its four truncated mutants used in the present study are illustrated in It has been demonstrated that the GFP-tagged corepressors, such as GFP-N-CoR and GFP-SMRT, showed intranuclear discrete dot patterns (46, 59) . As shown in Fig. 1B and C, full-length N-CoRs tagged with FLAG in fixed cells or GFP in living cells were located in the nucleus and showed a discrete dot structure with diffuse background. A similar distribution pattern of GFP-N-CoR was also observed in living 3T3-L1 cells and LNCaP cells derived from prostatic cancer (data not shown).
Then, subcellular distributions of the four GFP-tagged truncated mutants of the N-CoR, as illustrated in Fig. 1A , were observed by the laser confocal microscopy. As shown in Fig.  1D , the GFP-N-CoR(1-1798), which lacks the three IDs, showed an intranuclear discrete dot structure on a diffuse fluorescence background, which was a pattern identical to that of the full-length N-CoR. The distribution pattern of the middle region of N-CoR, GFP-N-CoR(1134-1798) (Fig. 1F ) was similar to that of the full-length N-CoR and N-CoR(1-1798), whereas the N-terminal mutant GFP-N-CoR(1-1133) was homogeneously distributed in the nucleus (Fig. 1E) . Moreover, the C-terminal mutant GFP-N-CoR(1803-2439), which has been previously reported to be sufficient for the repression effect of the N-CoR (9), was diffusely distributed in the cytoplasm but not in the nucleus (Fig. 1G) , as was reported for the C-terminal mutant of SMRT (64). Subnuclear redistribution of the N-CoR by agonist-bound steroid hormone receptors. As we previously reported (56) , although the AR was initially diffusely distributed in the cytoplasm (Fig. 2Aa) , it rapidly moved into the nucleus and made fine foci upon DHT treatment in living COS-7 cells (Fig. 2Ab) . Similarly, unliganded GR␣-GFP resided in the cytoplasm (Fig.  2Da ), while Dex triggered nuclear translocation and focus formation of the receptor (Fig. 2Db) . On the other hand, ER␣-GFP was homogeneously distributed in the nucleus, even in the absence of the ligand (Fig. 2Ga) , and it formed subnuclear foci in the presence of E 2 (Fig. 2Gb) .
The designation of subnuclear compartments of nuclear receptors and cofactors has not been defined concisely in many reported studies. In the present study, we define "foci" as small and clear speckles of agonist-bound steroid hormone receptors and "dots" as relatively large and discrete speckles.
To study spatial relationships of N-CoR with various steroid hormone receptors, we examined subnuclear distributions of YFP-N-CoR in the coexistence of the AR, GR␣, and ER␣ in living COS-7 cells. In the absence of DHT, AR-GFP and YFP-N-CoR were separately located in the cytoplasm and the nucleus, respectively ( Fig. 2Bi to 2Biii ). These patterns were the same as those observed when the two proteins were individually transfected. In the presence of the ligand, AR-GFP was translocated from the cytoplasm into the nucleus and showed focus formation (Fig. 2Ci) . Surprisingly, YFP-N-CoR was also reorganized and formed intranuclear foci ( Fig. 2Cii) and colocalized with the DHT-induced AR-GFP foci (Fig.  2Ciii ). This phenomenon was also observed in the LNCaP prostate cancer cells (data not shown). As well as the AR and N-CoR, GR␣-GFP moved from the cytoplasm into the nucleus and formed foci after treatment with Dex, and YFP-N-CoR was redistributed and colocalized with GR␣-GFP ( Fig. 2E and  F) . In the case of ER␣ and N-CoR, although both proteins resided in the nucleus, even in the absence of E 2 , they were not completely colocalized because of the discrete dot formation of YFP-N-CoR (Fig. 2H) . Again, the addition of E 2 induced focus formation of both ER␣-GFP and YFP-N-CoR (Fig. 2Ii  to 2Iii ). Ligand-dependent colocalization of the two proteins was confirmed by a merged image (Fig. 2Iiii) .
These data indicate that the corepressor N-CoR is relocated by steroid hormone receptors in the presence of the agonists.
Reduced subnuclear mobility of the N-CoR by DHT-bound ARs. A majority of nuclear proteins, including steroid hormone receptors and cofactors, are now believed to be dynamic in the nucleus (6, 16, 29) . Previous FRAP analyses showed that steroid hormone receptors, together with their colocalized coactivators, became less mobile upon treatment with cognate . Treatment with 10 nM DHT was unable to alter the recovery speed of GFP-N-CoR (data not shown). In the presence of the ligand, AR-GFP was less dynamic than the N-CoR (Fig. 3B) , and the t 1/2 for DHT-bound AR-GFP was 7.1 Ϯ 2.0 s (n ϭ 32). Standardized fluorescence recovery curves of both proteins clearly indicate that GFP-N-CoR is more dynamic than AR-GFP (Fig. 3D) . Then, GFP-N-CoR was cotransfected with a nonfluorescent AR (pCMV-AR), and the dynamics of GFP-N-CoR were examined by FRAP analysis. After the addition of DHT, cells whose N-CoR patterns were altered to intranuclear foci were subjected to FRAP analysis. These cells were expected to express both GFP-N-CoR and nonfluorescent ARs (Fig. 3C) . Interestingly, dynamics of GFP-N-CoR containing DHT-bound ARs apparently decreased compared to that of GFP-N-CoR alone (Fig. 3D ). In the absence of DHT, GFP-N-CoR cotransfected with the AR showed a t 1/2 of 4.6 Ϯ 0.9 s (n ϭ 20), which was similar to that of single transfected GFP-N-CoR. DHT treatment significantly prolonged the t 1/2 of GFP-N-CoR to 7.3 Ϯ 2.0 s (n ϭ 20) (Fig. 3E) . These results suggest that the N-CoR interacts with DHT-bound ARs and that the N-CoR is recruited into a complex of ARs. The intranuclear discrete dots of N-CoR are not colocalized with either the splicing factor compartments or PML nuclear bodies. The spatial relationships between N-CoR and two wellcharacterized subnuclear components, the splicing factor compartments (SFCs) and PML-NBs, were examined by immunofluorescence staining of MCF-7 cells. As previously reported (55, 67) , the numbers of intranuclear speckles per nucleus in MCF-7 cells were 20 to 40 for SFCs and 5 to 20 for PML-NBs (data not shown). As shown in Fig. 4A , the discrete intranuclear dots of GFP-N-CoR were not colocalized with either SFCs or PML-NBs. Next, we tested whether the distributions of SFCs and PML-NBs changed in the presence of ligandbound AR. In the absence of ligand, AR-GFP was diffusely distributed in the cytoplasm, while both SFCs and PML-NBs existed as distinct subnuclear dots. In the presence of DHT, AR-GFP formed distinct nuclear foci, but the intranuclear distributions of SFCs and PML-NBs were not affected by the formation of these foci. These results suggest that redistribution by activated AR is specific to N-CoR. To examine the effect of the middle region of the N-CoR on steroid hormone receptor-mediated transcriptional activation, functional promoter assays were performed using each hormone's responsive element. As shown in Fig. 6 , AR-, GR␣-and ER␣-mediated transcriptional activations were all suppressed by the N-CoR. Transactivation activities of these receptors were suppressed to 30 to 64% of the original activities by a 3 M excess coexpression of the N-CoR. As expected, the N-CoR(1-1798) and the middle region, N-CoR(1134-1798), also exhibited a suppression effect on all three reporters. In the case of AR and ER␣, both N-CoR(1-1798) and N-CoR(1134-1798) showed an even more potent suppression than the full-length N-CoR (Fig. 6A and  C) . In contrast, no significant suppression of promoter activities was observed by coexpression of N-CoR (Fig. 1A) , was able to interact with AR in CoIP (Fig. 7C ). This N-CoR(1134-1798) mutant also repressed the AR-mediated transactivation as well as the full-length N-CoR and N-CoR(1-1798) (Fig. 6A) , whereas NCoR(1-1133), which contains RD1 and 2, interacted with AR ( Fig. 7C ) but failed to repress the transactivation (Fig. 6A) . These results suggest that N-CoR(1134-1798) can bind with AR and would be enough to repress the AR-mediated transactivation function.
The intranuclear complete/distinct focus formation of agonist-bound steroid hormone receptor is an indicator of the transcription activation status. Intranuclear compartmentalization of steroid hormone receptors are so far mostly demonstrated using the exogenously expressed GFP-tagged receptors by laser confocal microscopy (13, 17, 22, 30, 33, 34, 42, 48-50, 52, 53, 56) . In the present study, we examined the intracellular distribution of endogenous ARs in fixed 3T3-L1 cells, which were found to contain a relatively high quantity of ARs by immunofluorescence staining. The endogenous ARs were found to form intranuclear foci in the presence of DHT (Fig. 8Aa) . Ligand-dependent subnuclear focus formation of steroid hormone receptor is considered to be closely associated with the transcriptional activation mediated by the receptors (41, 56) . To clarify the mechanism of intranuclear compartmentalization, an effect of a transcription inhibitor, actinomycin D (Act D), on the intranuclear focus formation of endogenous AR was investigated in fixed 3T3-L1 cells. Unexpectedly, distinct endogenous AR foci were not detected when treated with Act D (Fig. 8Ab) . Then the effects of transcription inhibitors on the exogenously expressed steroid hormone receptors were also investigated in living COS-7 cells. Comparing to the fine foci of DHT-bound AR-GFP (Fig. 8Ba) , the treatment of Act D or ␣-amanitin markedly impaired the intranuclear focus formation of DHT-bound AR-GFPs, which were accumulated as vague speckles close to the nuclear membrane ( Fig. 8Bb and 8Bc) . The distribution pattern of E 2 -bound ER␣-GFPs was changed from focal to reticular (Fig. 8Bd to f) . Moreover, the intranuclear foci of Dex-bound GR␣-GFPs totally disappeared (Fig. 8Bg to i) . These results strongly suggested that focus formation does not precede transcriptional activation and also that an appearance of intranuclear foci of steroid hormone receptors reflects the transactivation function status.
Additionally, tamoxifen did not activate the transcription of the ERE-containing luciferase reporter by ER␣ (data not shown), but tamoxifen-bound ER␣ was reported to form concentrated subnuclear regions similar to foci (49). Then we compared the intranuclear distribution patterns of E 2 -or tamoxifen-bound ER␣-GFP in both two-and three-dimensional images. In two-dimensional images, these two distribution patterns seemed similar ( Fig. 8Bd and Ca). However, in three-dimensional images, E 2 -bound ER␣-GFP formed distinct foci, whereas tamoxifen-ER␣-GFP showed a reticular pattern ( Fig. 8Cb and Cc).
The N-CoR impairs intranuclear complete/distinct focus formation of ligand-bound steroid hormone receptors via its middle region. The results shown in Fig. 2 to 5 demonstrated that the agonist-induced intranuclear compartmentalization of steroid hormone receptors was accompanied by the recruitment of N-CoRs, while the N-CoR firmly suppressed the transactivation function of steroid hormone receptors (Fig. 6 ). These observations were apparently inconsistent with our current hypothesis. Accordingly, we precisely analyzed the AR focus pattern when coexpressed with the N-CoR using two-and threedimensional quantitative image analyses ( Fig. 9 and 10) . A quantitative analysis in a two-dimensional image for fluctuation of fluorescent intensity in the nucleus was previously established by Htun et al. (22) . A straight line was drawn across a target nucleus, and fluorescent intensities along the line were recorded by Zeiss LSM software. An average and a SD value of fluorescent intensities were calculated. A CV, which was equal to the SD divided by the average, was used as a degree of heterogeneity of nuclear protein distribution, namely, if the CV value was high, the distribution of the protein was heterogeneous. This method has been applied to analyses of the nuclear distribution of several nuclear receptors, such as the hGR␣ (43) and Ad4BP/SF-1 (12) . The CV values of these nuclear receptors significantly increased after treatment with cognate ligands, which meant a change in subnuclear distribution from a homogeneous to a heterogeneous pattern. In the case of AR-GFP coexpressed with YFP in the presence of DHT, the fluorescence intensity curve for AR-GFP manifested about 9 to 11 clear wave peaks (Fig. 9B) . The YFP signal was diffusely distributed in the nucleus and cytoplasm and showed no wave peak in the fluorescence intensity curve (Fig. 9B) , which represented a diffuse homogeneous distribution pattern. The calculated CV value of DHT-bound AR-GFP, 0.43, represented the intranuclear heterogeneous distribution (Fig. 9I) . Interestingly, when YFP-N-CoR was coexpressed, the wave peaks of AR-GFP became unclear (Fig. 9D) . Furthermore, the number of wave peaks in the fluorescence intensity curve was apparently decreased. The decreased CV value (0.29) for AR-GFP (Fig. 9I) suggested that the fluctuation of fluorescence intensity was reduced and the distribution pattern of AR-GFP became less heterogeneous with the coexpression of YFP-NCoR. Similarly, when coexpressed with YFP-N-CoR(1-1798) or YFP-N-CoR(1134-1798), the wave peaks in the fluorescence intensity curve for AR-GFP became unclear ( Fig. 9F and H) and the CV value decreased to 0.25 or 0.16 (Fig. 9I ). As shown in Fig. 9J , the CV value of AR-GFP significantly decreased with the coexpression of YFP-N-CoR, YFP-NCoR(1-1798), or YFP-N-CoR(1134-1798). As well as the AR, the fluorescence intensity curve for E 2 -bound ER␣-GFP manifested clear wave peaks (Fig. 9L ) and the CV value was 0.35 ( Fig. 9S) . As expected, when coexpressed with YFP-N-CoR, YFP-N-CoR(1-1798), or YFP-N-CoR(1134-1798), the wave peaks in the fluorescence intensity curve for ER␣-GFP became unclear ( Fig. 9N , P, and R) and the CV values significantly decreased ( Fig. 9S and T) , representing a relatively homogeneous distribution of ER␣-GFP.
The impairment of complete/distinct focus formation by the N-CoR was further confirmed by three-dimensional image analyses (Fig. 10) . The three-dimensional construction method for confocal images allowed us to observe intranuclear fluorescent proteins at a high resolution and to quantify the number of fluorescent spots in the nucleus (41, 56) . This method can detect only a distinct volume (complete foci) by removing background scattering fluorescence and relatively diffusely distributed fluorescence and then clearly showing a difference in the intranuclear spatial distribution of the foci. With the coexpression of YFP, 167 intranuclear foci of AR-GFP were detected as a distinct volume in one nucleus (147 Ϯ 24, n ϭ 12) (Fig. 10Ai) . However, coexpression of YFP-N-CoR clearly decreased the number of intranuclear foci of AR-GFP to 93, as shown in Fig. 10Aii (80 Ϯ 31, n ϭ 12, P ϭ 0.0001 versus AR-GFP with YFP). Moreover, as well as the full-length NCoR, both N-CoR(1-1798) and N-CoR(1134-1798) destroyed the DHT-induced AR focus formation (Fig. 10Aiii and Aiv). In addition, the impairment of the complete/distinct ER␣ focus formation by the N-CoR via its middle region was also confirmed by three-dimensional image analyses. As shown in while an interaction between the C-terminal N-CoR(1803-2439) and AR-AF-1 was quite weak. These results suggest that the N-terminal region of the AR and N-CoR are major domains for the interaction between these two proteins. In the functional promoter assay, the middle region of the N-CoR was able to repress the AR-AF-1-mediated transactivation to the same level as that of the full-length N-CoR, whereas the amino-terminal and carboxyl-terminal regions of the N-CoR could not repress the transactivation (Fig. 11B) . As we previously reported (41), AR-AF-1 was located in the nucleus and formed foci even in the absence of DHT (Fig. 11C) . Interestingly, similar to GFP-N-CoR, both GFP-N-CoR(1-1798) and GFP-N-CoR(1134-1798) (Fig. 11Di) , when coexpressed with nonfluorescent AR-AF-1, formed intranuclear foci ( Fig. 11Dii and Div). However, N-CoR(1-1133) was still homogeneously distributed in the nucleus, and N-CoR(1803-2439) remained in the cytoplasm even when AR-AF-1 was coexpressed ( (28) . AR-mediated activation of the prostate-specific antigen (PSA) promoter was apparently enhanced by the addition of a specific HDAC inhibitor, TSA (Fig. 12A ) (19) . However, suppression of AR-mediated transactivation by the full-length N-CoR, N-CoR(1-1798), and N-CoR(1134-1798) was not significantly recovered by TSA. Similar results were obtained in case of the ER␣ (data not shown). In addition, TSA had no effect on the subcellular distribution of the AR, GR␣, or ER␣ in the presence of cognate ligands when coexpressed with the N-CoR (data not shown). These results suggest that there would be some mechanisms for repression of AR-mediated transactivation by the N-CoR other than the recruitment of HDAC.
It has been suggested that the agonist-induced N-C interaction is required for the full activity of the AR (2, 24, 41) . To examine an effect of the N-CoR on the AR N-C interaction, we performed a mammalian two-hybrid assay using VP16-fused AR-AF-1 and Gal4-fused AR-AF-2 (Fig. 12B) . In the absence of the ligand, VP16-AR-AF-1 and Gal4-AR-AF-2 exhibited almost no interaction. As a result of the interaction between Gal4-AR-AF-2 and VP16-AR-AF-1, the addition of DHT strongly stimulated the activation of the pG5 reporter. Coexpression of equimolar amounts of the N-CoR suppressed this ligand-dependent activation by 40%, indicating that N-CoRs suppress the AR N-C interaction. N-CoR(1-1798) and N-CoR (1134-1798) also suppressed the N-C interaction by 20% and 60%. The disturbance of the AR N-C interaction by these N-CoR mutants was more evident at increasing amounts (Fig. 12B) . In contrast, N-CoR(1803-2439) did not inhibit the AR N-C interaction (data not shown). Similar results were obtained with NIH 3T3 cells (data not shown). These results strongly suggest that the N-CoR inhibits the transactivation activity of the AR by disturbing N-C interactions mainly through its middle region.
Some coactivators can enhance AR-mediated transcriptional activation through stabilization of the AR N-C interaction by direct binding to the N-terminal AF-1 domain (7, 24) . In the mammalian two-hybrid assay, SRC-1 or CBP dosedependently recovered the suppression of N-C interaction by the N-CoR (Fig. 12C) . Conversely, coexpression of an increasing amount of N-CoRs suppressed the enhancement effects of SRC-1 or CBP. A similar tendency was observed in the functional reporter assay using the mouse mammary tumor virus (MMTV) promoter (Fig. 12D) . The repression of AR-mediated transactivation by the N-CoR was dose-dependently recovered by coexpressing an increasing amount of coactivator, SRC-1 or CBP. Moreover, the N-CoR strongly repressed the coactivation effects of SRC-1 or CBP. These results suggest that the functional competition with the coactivaors by the N-CoR may be one of the mechanisms of N-CoR-mediated repression.
Release of the N-CoR from intranuclear foci of AR-GFP by coexpression of SRC-1 and CBP. We then investigated the intranuclear distribution of the YFP-N-CoR and DHT-bound AR-GFP in living cells when the cells were cotransfected with relatively higher levels of the expression plasmids for coactivators, SRC-1 and CBP, compared with that for N-CoRs. The N-CoR was originally located in the nucleus with a discrete dot structure ( Fig. 1 and 2 ). In the presence of DHT, localization of AR-GFP and YFP-N-CoR almost overlapped due to the redistribution of YFP-N-CoR and discrete dots of YFP-NCoR disappeared (Fig. 2C and 13A) . Interestingly, if the cells were cotransfected with nonfluorescent SRC-1 (Fig. 13B) or CBP (Fig. 13C) , the red dots of YFP-N-CoR reappeared ( Fig.  13Bii and Cii). In the merged and enlarged images, these red dots were observed separated from the green signal of AR-GFP ( Fig. 13Biv and Civ). This strongly suggests that YFP-NCoR was released from the AR compartment when coactivators were coexpressed.
Using the three-dimensional imaging technique, the number of discrete YFP-N-CoR dots was 155 (Fig. 13G) when the cells were transfected with YFP-N-CoR only. The number of distinct foci of AR-GFP was decreased to 79 by coexpression with YFP-N-CoR (Fig. 13Di) , as shown in Fig. 10 . No YFP-N-CoR signal was detected after processing of the three-dimensional reconstruction (Fig. 13Dii) , suggesting that the original discrete dots of YFP-N-CoR disappeared by redistribution (Fig.  13Aii) and the relatively homogeneously redistributed YFP-N-CoR was not included in distinct foci of AR-GFP. When SRC-1 or CBP was coexpressed, the number of distinct foci of AR-GFP was recovered to 138 and 135 ( Fig. 13Ei and Fi) . Moreover, discrete dots of YFP-N-CoR were detected ( Fig.  13Eii and Fii) and localized separately from the distinct foci of AR-GFP in the merged images ( Fig. 13Eiii and Fiii) . The number of dots of YFP-N-CoR was approximately 140 per nucleus, which was similar to that observed with transfection of YFP-N-CoR alone. These results further confirmed that YFP-N-CoR was released from intranuclear compartments of agonist-bound AR-GFP and then formed discrete dots by coexpression of coactivators SRC-1 and CBP. When AR-GFP and YFP-SRC-1 were transfected with the nonfluorescent N-CoR, SRC-1 was found to form distinct foci with AR-GFP, showing a yellow signal in the merged three-dimensional image (Fig. 13H) .
To determine whether endogenous N-CoR shows the same intranuclear distribution pattern as GFP-N-CoR, we performed an immunofluorescence staining study using anti-NCoR antibody. In the absence of DHT, N-CoR was distributed in the form of discrete intranuclear dots in a diffuse background signal (Fig. 14Ai) . Similar to the results obtained with GFP-tagged N-CoR, the endogenous N-CoR dots disappeared in the presence of DHT to form intranuclear foci (Fig. 14ii) . These results suggest that endogenous N-CoR is also redistributed by ligand-bound endogenous AR.
We further examined the redistribution of endogenous NCoRs by coexpressing AR-GFP in 3T3-L1 cells. In the absence of DHT, endogenous N-CoR, which was detected by immunostaining, and AR-GFP were separately located in the cytoplasm and the nucleus (Fig. 14B ). These distribution patterns were similar to those observed when the two proteins were cotransfected ( Fig. 2Bi to iii) . In the presence of DHT, AR-GFP was translocated into the nucleus and formed intranuclear foci (Fig. 14Ci) . Simultaneously, the intranuclear discrete dots of endogenous N-CoRs disappeared (Fig. 14Cii ) and endogenous N-CoR proteins were recruited into the DHT-bound AR foci ( Fig. 14Ciii and Civ). When the cells were cotransfected with nonfluorescent SRC-1 (Fig. 14D) or CBP (Fig.  14E) , the red dots of endogenous N-CoRs reappeared ( Fig.  14Dii and Eii) and were separated from the green signals of AR-GFP (Fig. 14Diii to iv and Eiii to iv). Expression of endogenous N-CoR, which was estimated by the intensity of fluorescence on laser confocal microscopy, was not affected by the overexpression of SRC-1 or CBP detected in this assay (data not shown). These results strongly suggest that the endogenous N-CoR is also recruited into AR foci in a liganddependent manner and released from the AR compartment by overexpression of coactivators.
DISCUSSION
The present study provides novel findings about mechanisms of repression of steroid hormone receptor function by the N-CoR. The N-CoR was recruited to subnuclear foci formed by agonist-bound steroid hormone receptors, but the recruited N-CoR impaired complete focus formation, reflecting its inhibitory effect on transactivation. The middle region of the N-CoR, N-CoR(1134-1798), was mostly responsible for both the interaction with steroid hormone receptors and the repression of their activities. The repression mechanism included disruption of the N-C interaction of the receptors and/or competition with the coactivators, such as SRC-1 and CBP, rather than recruitment of HDACs.
We demonstrated that both the endogenous and exogenous N-CoR proteins formed discrete dot structures with a diffuse background and were redistributed and colocalized with agonist-bound steroid hormone receptors. Similar redistributions of corepressors have been observed by other researchers. For example, Dex-bound endogenous GR␣ redistributed a corepressor, receptor-interacting protein 140, from its intranuclear dots to a more diffuse pattern, and the redistribution of receptor-interacting protein 140 was correlated with its repression of GR-mediated transactivation (53) . GFP-SMRT was reorganized to more reticular, microspeckled pattern by ligandbound ER␣, which was colocalized with ligand-bound ER␣ (58) . Furthermore, the redistribution of corepressors was also induced by other classes of transcription factors, such as pituitary-gland-specific Pit-1. Both SMRT and N-CoR repressed Pit-1-mediated transcription, and the intranuclear dot structures of SMRT and N-CoR were changed to more diffuse nucleoplasmic compartments with the coexpression of Pit-1 (59) . In contrast, in the present study, the distributions of two well-characterized nuclear compartments, SFCs and PMLNBs, were not affected by ligand-bound AR, indicating that the redistribution of N-CoR by agonist-bound AR is not a secondary event induced by the possible alteration of nuclear architecture. Thus, this widely observed redistribution of corepressors may be a common and specific process during the regulation of transcription activity by the corepressors.
The redistribution of N-CoR by steroid hormone receptors and the interaction of N-CoR with those receptors occurred in an agonist-dependent manner. Interactions between the NCoR and AR or GR␣ have so far been demonstrated by binding assays such as glutathione S-transferase pull-down and two-hybrid assay (9, 33) , and previous studies were mostly focused on ligand-independent interactions between the domains of N-CoRs and steroid hormone receptors. We also demonstrated the interaction between the N-CoR and agonistbound AR in living cells by FRAP analysis. The N-CoR became less mobile by coexpression of ARs in the presence of DHT. It has been revealed that, although most steroid hormone receptors are highly dynamic in the nucleoplasmic space, the mobility of the receptors decreases in the presence of ligand (6, 17, 40, 42, 48) . Steroid receptors were detected in a nuclear matrix preparation after treatment with ligands (4), and such an interaction would be necessary for transactivation. The decrease in mobility is presumed to come from the interaction of ligand-bound receptors with the nuclear matrix. Therefore, the decreased mobility of the N-CoR was thus considered to reflect a direct and functional interaction of N-CoRs with liganded ARs.
Previous studies showed that the carboxyl-terminal region of N-CoR/SMRT, containing a CoRNR motif (I/LXXII), was enough for the repression of the transactivation of nuclear receptors (9, 23, 44, 63) . However, our results found that the middle region of the N-CoR, N-CoR(1134-1798), exerted a significant inhibitory effect on the transactivation function of steroid hormone receptors but not the amino-or carboxylterminal region of the N-CoR (Fig. 6) . In previous studies, strong interactions between the C terminus of N-CoR and steroid hormone receptors were detected in the absence of the ligand (9) or in the presence of antagonists (44, 60) . Although Cheng et al. showed a repression of DHT-induced AR transactivation by the C terminus of N-CoR, the interaction be- tween the N-CoR C terminus and AR was ligand independent. Moreover, in the mammalian two-hybrid assay for AR-N-CoR interaction analysis, the authors used AR-ligand binding domain, not the full-length of the receptor. In fact, in a recent study by Hodgson et al., DHT-dependent interaction between the C terminus of N-CoR and the full-length AR was not detected (20) , which corresponds with our present results ( Fig.  1 and 6 ). Therefore, it is supposed that the middle region may be important for the agonist-dependent interaction between N-CoR and AR, whereas the C terminus of N-CoR may be important for the antagonist-induced interaction. In the present study, the middle region of the N-CoR, N-CoR(1134-1798), but not the amino-or carboxyl-terminal region of the N-CoR, was recruited by agonist-bound AR, GR␣, and ER␣ in living cells (Fig. 5) . Furthermore, coimmunoprecipitation experiments revealed that N-CoR(1134-1798) containing RD3 was able to interact with the AR. Therefore, N-CoR(1134-1798) containing RD3 is strongly suggested to be the major region for the repression of transactivation function of agonistbound steroid hormone receptors. The N-CoR(1-1133) also contributes to the interaction with agonist-bound receptors but does not seem to be responsible for the repression of their transactivation function ( Fig. 6 and 7 ). Many coactivators have been shown to regulate AR transactivation function through an interaction with the N-terminal domain of the AR. The p160 coactivators such as SRC-1 and TIF2 directly interacted with the N-terminal domain of the AR (2). It has previously been reported that SRC-1 and TIF2 were recruited into the AR-AF-1 foci (41) . The N-CoR protein was also shown to interact with the N-terminal domain of steroid hormone receptors (20, 44, 60) . In the present study, the NCoR was also recruited to the AR-AF-1 foci, and the interaction between N-CoR and AR-AF-1 was confirmed by mammalian one-hybrid assay. The N-CoR is thus suggested to repress AR-mediated transactivation through an interaction with the N-terminal domain of the AR.
We demonstrated that the N-CoR inhibited the AR N-C interaction in the mammalian two-hybrid assay and also in the AR-mediated transactivation. A specific HDAC inhibitor, TSA, could not recover the N-CoR-mediated suppression of AR-dependent transactivation (Fig. 12A) . It has been recently reported that SMRT-mediated inhibition of the steroid hormone receptor function is not recovered by TSA (1, 23) and is largely due to the blockage of the AR N-C interaction (1, 34) . In the present study, we confirmed that N-CoR also had such inhibitory effects on the AR N-C interaction. In a recent paper (32) , it has been reported that the intramolecular N-C interaction controls AR chromatin binding and is required for the recruitment of SWI/SNF, which remodels chromatin. Inhibition of intramolecular interactions by N-CoR might affect chromatin remodeling, resulting in repression of the transactivation function.
Recently, it was proposed that coactivators and corepressors exert equilibrium interactions with nuclear receptors (61) and that the properties of nuclear receptors are determined by the intracellular ratio of coactivators and corepressors (45, 51, 61) . It was also proposed that the transcriptional regulation by nuclear receptors requires the corepressor-coactivator exchange via the TBL1/TBLR1-containing exchange complex (39) . Competition between N-CoR and coactivators to regulate N-C interaction and the transactivation activity of AR was revealed in the present study, which seems consistent with the above hypothesis.
The appearance of intranuclear focus formation has been shown to be closely related to the transcriptionally active conformation of steroid hormone receptors with coactivators (13, 30, 41, 56) . Upon treatment with DHT, AR-GFP alone formed complete foci with recruitment of coactivators such as SRC-1, TIF2, and CBP (41) . Such focus formation was clearly demonstrated for endogenous AR in the present study (Fig. 8A) . Treatment with some antagonists, which inhibit the transcriptional activation, translocates the receptors from the cytoplasm into the nucleus; however, the translocated receptors are not able to form intranuclear foci and are diffusely distributed (13, 56) . The N-C interaction is also required for complete focus formation of ARs (41) . However, the present study clearly demonstrated that the quality of AR foci or ER␣ foci containing the N-CoR was different from that of AR foci or ER␣ foci without N-CoRs. The focus pattern of AR-GFP and ER␣-GFP without N-CoRs (Fig. 2Ab and Gb and 9A and K) seemed much more distinct than the speckle pattern of AR-GFP and ER␣-GFP coexpressed with the N-CoR (Fig. 2Ci and Ii and 9C and M), but such differences in the appearance of the intranuclear compartments were not confirmed only by simple twodimensional images. However, a quantitative analysis of fluorescence intensity fluctuation in two-dimensional images and a three-dimensional imaging method we previously developed (41, 56) clearly demonstrated impaired formation of AR or ER␣ foci (incomplete focus formation) in the presence of the N-CoR (Fig. 9 and 10 ). The transactivation activities of AR and ER␣ were parallel at the level of their distinct (complete) focus formation ( Fig. 6 and 10) . It was thus suggested that only complete focus formation is related to the full transactivation function of ARs. An antagonist, tamoxifen, was shown to induce ER␣ focus formation, which was similar to foci induced by estradiol (Fig. 8Bd and Ca) . However, the present study demonstrated that the tamoxifen-induced foci of ER␣ are not complete foci (Fig. 8Cb and Cc). The biochemical analyses using the two-hybrid and reporter gene assays revealed the functional competition between the N-CoR and CBP/SRC-1 on transactivation activity of the AR. This finding would further conceive that the N-CoR and coactivators mutually and exclusively bind to ARs, namely, binding of CBP and SRC-1 leads to a change in molecular conformation of the AR that hinders further binding of N-CoRs and vice versa. The present three-dimensional imaging analysis provided evidence for the above concept. Additional expression of SRC-1 or CBP in DHT-bound ARs coexpressed with N-CoRs led to release of N-CoRs from incomplete foci containing DHT-bound ARs and N-CoRs and to formation of distinct/complete foci with the coactivators (Fig. 13) . Essentially the same phenomena were observed for endogenous N-CoR (Fig. 14) . We speculate that there is a conformational equilibrium between transcriptionally active and inactive steroid hormone receptors in the presence of agonists, determined by the relative ratio of coactivators and corepressors.
The present observations that transcription inhibitors, actinomycin D and ␣-amanitin, disrupt intranuclear foci of steroid hormone receptors (Fig. 8B) on January 27, 2018 by guest http://mcb.asm.org/ steroid hormone receptors and coactivators show multiphasic on and off switching for binding to promoter elements of the target genes. The receptor-coactivator complexes also undergo a rapid exchange between the target genes and their subnuclear compartments (34, 35, 48) . Based on these reported observations and the present findings that complete focus formation is related to the transcriptional activation, it is suggested that complete focus formation of steroid hormone receptors reflects the accumulation of steroid hormone receptor-coactivator complexes released from their target genes. Therefore, it is further suggested that focus formation is a mirror of transcriptionally active complex formation of steroid hormone receptors and coactivators at transcription sites. Thus, investigation of focus formation would be useful for the elucidation of the mechanism of steroid hormone receptordependent transactivation in living cells. A physiological role for focus formation still remains to be clarified. One speculated possibility is as follows. Numerous important molecules are functioning in the nucleus. Some regulatory mechanisms for these molecules should be present. Focus formation might be one of these mechanisms, and foci function as temporary storing and buffering sites that are related to steroid hormone receptor cycling. Figure 15 summarizes the speculation of the intranuclear compartmentalization and transactivation function of the AR based on the present findings.
